ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 26 filers reported holding ENVVENO MEDICAL CORPORATION in Q4 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $491,000 | – | 74,478 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 781,615 | $4,212,905 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,181,380 | 0.14% |
| UBS OCONNOR LLC | 226,308 | $1,219,800 | 0.03% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 14,000 | $75,460 | 0.02% |
| Tamar Securities, LLC | 13,990 | $75,407 | 0.02% |
| Fermata Advisors, LLC | 11,850 | $63,873 | 0.02% |
| DIMENSIONAL FUND ADVISORS LP | 18,309 | $98,685 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,063 | $11,120 | 0.00% |
| NORTHERN TRUST CORP | 17,074 | $92,029 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |